What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Diabetes mellitus
His primary areas of study are Internal medicine, Endocrinology, Insulin resistance, Adiponectin and Insulin.
His Internal medicine study combines topics from a wide range of disciplines, such as Diabetes mellitus and AMPK.
His study in Diabetes mellitus is interdisciplinary in nature, drawing from both Genotype and Intensive care medicine.
Takashi Kadowaki interconnects Receptor and Peroxisome proliferator-activated receptor in the investigation of issues within Endocrinology.
His biological study spans a wide range of topics, including Glucose uptake and Allele.
His research in Adiponectin intersects with topics in Hormone, Adipokine and Beta oxidation.
His most cited work include:
- The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity (4196 citations)
- Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase (3697 citations)
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effects (2607 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Endocrinology, Diabetes mellitus, Type 2 diabetes and Insulin resistance.
The various areas that he examines in his Internal medicine study include Gastroenterology and Type 2 Diabetes Mellitus.
His Endocrinology research incorporates themes from Receptor and Peroxisome proliferator-activated receptor.
His Diabetes mellitus research is multidisciplinary, relying on both Obesity, Surgery, Incidence and Intensive care medicine.
His Type 2 diabetes research includes elements of Hypoglycemia and Genetics.
Insulin resistance is closely attributed to Leptin in his research.
He most often published in these fields:
- Internal medicine (56.56%)
- Endocrinology (43.34%)
- Diabetes mellitus (28.09%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (56.56%)
- Diabetes mellitus (28.09%)
- Type 2 diabetes (21.33%)
In recent papers he was focusing on the following fields of study:
Takashi Kadowaki focuses on Internal medicine, Diabetes mellitus, Type 2 diabetes, Endocrinology and Insulin resistance.
He works in the field of Internal medicine, namely Insulin.
His studies deal with areas such as Obesity and Intensive care medicine as well as Diabetes mellitus.
His Type 2 diabetes study incorporates themes from Observational study, Genome-wide association study, Incidence, Kidney disease and Genetic association.
Takashi Kadowaki combines subjects such as Inflammation and Downregulation and upregulation with his study of Endocrinology.
As part of one scientific family, Takashi Kadowaki deals mainly with the area of Insulin resistance, narrowing it down to issues related to the Receptor, and often Adiponectin receptor 1.
Between 2015 and 2021, his most popular works were:
- Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial (113 citations)
- Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease (109 citations)
- Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial (107 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Internal medicine, Endocrinology, Type 2 diabetes, Diabetes mellitus and Insulin resistance are his primary areas of study.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Placebo and Type 2 Diabetes Mellitus.
His study in Endocrinology focuses on Adiponectin, White adipose tissue, Adipose tissue, Lipid metabolism and Adipocyte.
His Type 2 diabetes research incorporates elements of Genetics, Genome-wide association study, Surgery, Diabetic nephropathy and Bioinformatics.
His Diabetes mellitus research is multidisciplinary, incorporating elements of Medical prescription and Genetic association.
His biological study deals with issues like Glucose uptake, which deal with fields such as Glucose clamp technique, Adipose triglyceride lipase, Tofogliflozin and Anagliptin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
